ETS2 and inflammatory bowel disease: Colony-stimulating factor 1 receptor signaling promotes the differentiation of monocytes into tolerant intestinal macrophages by downregulating the transcription factor ETS2, while noncoding variants at the ETS2 locus may disrupt this process and thereby increase IBD risk (170).